Abstract |
Although HMG-CoA reductase inhibitors such as statins are the most widely used cholesterol-lowering agents, there is a risk of myopathy or rhabdmyolysis occurring in patients taking these drugs. It has been reported that a number of lipophilic statins cause apoptosis in various cells, but it is still not clear whether intracellular acidification is involved in statin-induced apoptosis. There have been few studies aimed at identifying compounds that suppress statin-induced myotoxicity. In the present study, we examined the relationship between cerivastatin-induced apoptosis and intracellular acidification and the effect of bicarbonate on cerivastatin-induced apoptosis using an RD cell line as a model of in vitro skeletal muscle. Cerivastatin reduced the number of viable cells and caused dramatic morphological changes and DNA fragmentation in a concentration-dependent manner. Moreover, cerivastatin-induced apoptosis was associated with intracellular acidification and caspase-9 and -3/7 activation. On the other hand, bicarbonate suppressed cerivastatin-induced pH alteration, caspase activation, morphological change and reduction of cell viability. Accordingly, bicarbonate suppressed statin-induced apoptosis. The strategy to combine statins with bicarbonate can lead to reduction in the chance of the severe adverse events including myopathy or rhabdmyolysis.
|
Authors | Masaki Kobayashi, Fumie Kaido, Toshiki Kagawa, Shirou Itagaki, Takeshi Hirano, Ken Iseki |
Journal | International journal of pharmaceutics
(Int J Pharm)
Vol. 341
Issue 1-2
Pg. 181-8
(Aug 16 2007)
ISSN: 0378-5173 [Print] Netherlands |
PMID | 17553641
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Fluorobenzenes
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Protective Agents
- Pyridines
- Pyrimidines
- Sulfonamides
- Rosuvastatin Calcium
- Sodium Bicarbonate
- cerivastatin
- CASP9 protein, human
- Caspase 3
- Caspase 7
- Caspase 9
|
Topics |
- Apoptosis
(drug effects)
- Biological Transport
- Caspase 3
(metabolism)
- Caspase 7
(metabolism)
- Caspase 9
(metabolism)
- Cell Line, Tumor
- Cell Shape
(drug effects)
- Cell Survival
(drug effects)
- DNA Fragmentation
(drug effects)
- Dose-Response Relationship, Drug
- Enzyme Activation
- Fluorobenzenes
(metabolism, toxicity)
- Humans
- Hydrogen-Ion Concentration
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(metabolism, toxicity)
- Muscle, Skeletal
(drug effects, metabolism, pathology)
- Protective Agents
(pharmacology, therapeutic use)
- Pyridines
(metabolism, toxicity)
- Pyrimidines
(metabolism, toxicity)
- Rhabdomyolysis
(chemically induced, metabolism, pathology, prevention & control)
- Rhabdomyosarcoma, Embryonal
(metabolism, pathology)
- Rosuvastatin Calcium
- Sodium Bicarbonate
(pharmacology, therapeutic use)
- Sulfonamides
(metabolism, toxicity)
|